about
Understanding the evolution of multimorbidity: evidences from the North West Adelaide Health Longitudinal Study (NWAHS).Polypharmacy in multimorbid older adults: protocol for a systematic review.Acetylsalicylic acid for primary prevention of cardiovascular diseases in older patients with diabetes: do the benefits overcome the risks?Association Between Loyalty to Community Pharmacy and Medication Persistence and Compliance, and the Use of Guidelines-Recommended Drugs in Type 2 Diabetes: A Cohort Study.Persistence patterns with oral antidiabetes drug treatment in newly treated patients--a population-based study.Efficacy of school-based interventions aimed at decreasing sugar-sweetened beverage consumption among adolescents: a systematic review.Quebec Integrated Chronic Disease Surveillance System (QICDSS), an innovative approach.Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetes.Underuse of cardioprotective treatment by the elderly with type 2 diabetes.Association between nutrition and the evolution of multimorbidity: the importance of fruits and vegetables and whole grain products.Difficulty adhering to antidiabetic treatment: factors associated with persistence and compliance.Pharmacy record registration of acetyl salicylic acid (ASA) prescriptions in Quebec.Community-dwelling older people's attitudes towards deprescribing in Canada.Comparative effectiveness of cardioprotective drugs in elderly individuals with type 2 diabetesQ59654407Loyalty To A Pharmacy Is Associated With A Better Quality Of Antidiabetes Drug UseAssociation between age and the initiation of antihypertensive, lipid lowering and antiplateletet medications in elderly individuals newly treated with antidiabetic drugsSuboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 DiabetesAnticoagulant use in patients with cancer associated venous thromboembolism: A retrospective cohort studyEffect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substratesPharmacist-led intervention to improve medication use in older inpatients using the Drug Burden Index: a study protocol for a before/after intervention with a retrospective control group and multiple case analysisBenefits, risks and impacts on quality of life of medications used in multimorbid older adults: a Delphi studyPolypharmacy and Pharmacological Treatment of Diabetes in Older Individuals: A Population-Based Study in Quebec, CanadaOne-year persistence of potentially inappropriate medication use in older adults: A population-based studyPolypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health
P50
Q33567877-E5A29199-32E6-4200-8370-2632E51BD3BAQ33709200-045DDF04-E647-4782-BDB5-030C348FCF7FQ33949522-7D080690-2FFF-4129-BF42-20FC763D9EEFQ35858245-669CB644-5DA9-4F5A-A105-F8D27286E8BAQ37807487-E7879F2B-22D1-4360-A13B-A89EB7A5032DQ38760266-E289C1F0-0CDF-48B5-A7C9-6FC826172E20Q39096372-DF782BE3-3C9F-4AC8-AFA4-F506D33EB8FFQ43563736-4AADF239-C9EE-43BD-979A-537AE7096256Q44569169-3A83BD8A-F8DA-4C34-8A5F-A8778FA22458Q44893973-C2F572DC-2015-496C-8033-7928B5607376Q46784149-AB81DAC2-953F-4B4F-93A3-23A77624E0E3Q47775952-3A9A723A-C202-481F-9AD5-3CFC15354442Q50144545-1F386BA1-CE2C-4DDC-B5A2-EFB9FE50BD67Q59654405-C3AF074E-3FB8-4F11-8D12-3DBD8CF8A719Q59654407-73234661-7C3F-4E16-86B3-73810EFC434DQ59654408-35D5B8BF-DF5F-4CD7-8161-BBA008369BE4Q59654411-FBA30833-7D74-46AA-88E2-03D50B5F2562Q59654412-6F5AB49E-5036-43D1-8D68-0CB0B15EDF49Q59654417-568283F1-3310-4E7C-9E1B-7EB57509CE90Q59654421-4B54FEA2-1267-46F1-B743-8AB2D728BFEEQ89837920-58481910-EECC-4DBA-A39C-8C73A9DF099BQ91265161-5F1E2BF0-6817-4AAE-AA3E-94105271F4F1Q91726618-A2BAD0D6-D0A1-47FE-AE77-816C8D08A9D9Q92509089-426BDFED-93F6-461D-B98E-5547D7354E62Q93016818-5907D54E-133B-4221-B1B4-D05FBE514427
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Caroline Sirois
@ast
Caroline Sirois
@en
Caroline Sirois
@es
Caroline Sirois
@nl
Caroline Sirois
@sl
type
label
Caroline Sirois
@ast
Caroline Sirois
@en
Caroline Sirois
@es
Caroline Sirois
@nl
Caroline Sirois
@sl
prefLabel
Caroline Sirois
@ast
Caroline Sirois
@en
Caroline Sirois
@es
Caroline Sirois
@nl
Caroline Sirois
@sl
P106
P108
P21
P31
P496
0000-0003-3294-7883